Jennison Associates »

Celldex Therapeutics shares owned by Jennison Associates

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Jennison Associates from 13F filings

Historical chart of Jennison Associates investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Jennison Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $29M 688k 41.97
2023-12-31 $796k 20k 39.66
2023-09-30 $740k 27k 27.52
2023-06-30 $45M 1.3M 33.93
2023-03-31 $57M 1.6M 35.98
2022-12-31 $69M 1.6M 44.57
2022-09-30 $36M 1.3M 28.11